London, United Kingdom

Brian H Anderton

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal2 out of 176 
 
King's College London
 patents
silverMedal1 out of 3 
 
Proteome Sciences Plc
 patents
bronzeMedal1 out of 832,891 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Brian H Anderton

Introduction

Brian H Anderton, an esteemed inventor based in London, GB, has made significant strides in the field of biotechnology and neuroscience. With a total of three patents to his name, his work primarily focuses on therapies targeting tau protein phosphorylation, crucial for the treatment of neurodegenerative diseases.

Latest Patents

Among his latest inventions, Anderton has developed methods for screening inhibitors of tau phosphorylation by casein kinase I. This innovation discloses methods for identifying substances capable of modulating the phosphorylation of tau protein, particularly the paired helical filament (PHF) tau. These findings are especially relevant in treating tauopathies, giving insight into therapeutic targets through the identification of new phosphorylation sites and kinases.

Another significant patent focuses on the method of screening for inhibitors of tau protein phosphorylation by the tyrosine kinase c-Abl. This invention provides groundbreaking techniques for screening candidate compounds that may help treat Alzheimer's disease and related conditions by specifically inhibiting the phosphorylation of tau protein by tyrosine kinase c-Abl.

Career Highlights

Anderton has had a notable career, including his tenure at King's College London, where he contributed to critical research in the field of neuroscience. His work underscores the intersection of innovation and medical science, highlighting the need for novel therapeutic approaches in combating neurodegenerative diseases.

Collaborations

Throughout his career, Anderton has collaborated with other distinguished researchers, including Malcolm Andrew Ward and Helen Louise Byers. Their collective efforts have advanced the understanding of tau-related pathologies and fostered innovations that may lead to significant breakthroughs in treatment methodologies.

Conclusion

Brian H Anderton's contributions as an inventor are noteworthy, particularly his patents which advance the field of neuroscience. His dedicated research and innovative methods aim to provide effective treatments for devastating conditions like Alzheimer's disease, reflecting a commitment to improving patient care through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…